Collectively, the convergence of TP53 mutations, hypoxia-driven stabilization, and MYC-mediated transcriptional reinforcement provides a compelling explanation for why SETDB1 is selectively overexpressed in the most aggressive HCC subtypes. The gene discussed is TP53; the disease is hepatocellular carcinoma.